These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Analysis of factor VIII inhibitors using hybrid human/porcine factor VIII. Lollar P. Thromb Haemost; 1997 Jul; 78(1):647-51. PubMed ID: 9198232 [Abstract] [Full Text] [Related]
7. Factors affecting choice of hemostatic agent for the hemophilia patient with an inhibitor antibody. Monahan PE, Aledort LM, Hemophilia Inhibitor Study Group. Am J Hematol; 2004 Dec; 77(4):346-50. PubMed ID: 15558804 [Abstract] [Full Text] [Related]
8. The use of intravenous immunoglobulins in the treatment of factor VIII inhibitors. Sultan Y, Kazatchkine MD, Algiman M, Dietrich G, Nydegger U. Semin Hematol; 1994 Apr; 31(2 Suppl 4):65-6. PubMed ID: 7939782 [No Abstract] [Full Text] [Related]
10. Association of anti-idiotypic antibodies with immune tolerance induction for the treatment of hemophilia A with inhibitors. Sakurai Y, Shima M, Tanaka I, Fukuda K, Yoshida K, Yoshioka A. Haematologica; 2004 Jun; 89(6):696-703. PubMed ID: 15194537 [Abstract] [Full Text] [Related]
11. Overview of inhibitors. Astermark J. Semin Hematol; 2006 Apr; 43(2 Suppl 4):S3-7. PubMed ID: 16690373 [Abstract] [Full Text] [Related]
12. Hemophilia. Strategies for the treatment of inhibitor patients. Ingerslev J. Haematologica; 2000 Oct; 85(10 Suppl):15-20. PubMed ID: 11187863 [Abstract] [Full Text] [Related]
13. Comments on the development of inhibitor antibodies in patients using recombinant factor VIII concentrates. Brettler DB. Semin Hematol; 1991 Apr; 28(2 Suppl 1):45-6. PubMed ID: 1908128 [No Abstract] [Full Text] [Related]
15. Factor VIII inhibitors in hemophilia. Mariani G. Bilt Hematol Transfuz; 1979 Apr; 7(1):3-41. PubMed ID: 121880 [No Abstract] [Full Text] [Related]
16. Inhibitors of factor VIII in hemophilia. Lacroix-Desmazes S, Dimitrov JD, Repesse Y. N Engl J Med; 2009 Jul 16; 361(3):308; author reply 310. PubMed ID: 19605840 [No Abstract] [Full Text] [Related]
17. Recombinant factor VIII in hemophilia. Cohen A, Butler R. N Engl J Med; 1991 May 23; 324(21):1515-6. PubMed ID: 1902552 [No Abstract] [Full Text] [Related]
18. [Therapy of immuninhibitor hemophilia A with FEIBA plasma fraction]. István L, Bariska I, Marton E. Orv Hetil; 1980 Dec 21; 121(51):3131-5. PubMed ID: 6784062 [No Abstract] [Full Text] [Related]
19. A detailed comparison of the performance of the standard versus the Nijmegen modification of the Bethesda assay in detecting factor VIII:C inhibitors in the haemophilia A population of Canada. Association of Hemophilia Centre Directors of Canada. Factor VIII/IX Subcommittee of Scientific and Standardization Committee of International Society on Thrombosis and Haemostasis. Giles AR, Verbruggen B, Rivard GE, Teitel J, Walker I. Thromb Haemost; 1998 Apr 21; 79(4):872-5. PubMed ID: 9569207 [Abstract] [Full Text] [Related]
20. Factor VIII inhibitors, natural history and management. Allain JP. Southeast Asian J Trop Med Public Health; 1979 Jun 21; 10(2):241-2. PubMed ID: 524148 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]